HC Deb 05 May 1994 vol 242 cc624-5W
Mr. Llwyd

To ask the Secretary of State for Health what discussions her Department has had with representatives of the pharmaceutical industry about research into new drugs for the treatment of Alzheimer's disease.

Dr. Mawhinney

As part of the day to day operations of the pharmaceutical price regulation scheme, manufacturers have kept officials in touch with progress on development and licensing of new drugs, including those for the treatment of Alzheimer's disease.